SCHEMBL323499

SCHEMBL323499

Cc1ccc(S(=O)(=O)OCC2CCC(CO)N2C(=O)OCC(C)C)cc1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.37
CYP2D6 P10635 2/20 0.36
P2RX4 Q99571 1/20 0.35
KMT2A Q03164 2/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
MDM2 Q00987 1/20 0.35
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
STAT3 P40763 1/20 0.34
KDM4E B2RXH2 1/20 0.34
CYP1A2 P05177 1/20 0.34
LMNA P02545 2/20 0.34
POLB P06746 1/20 0.34
MAPK1 P28482 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18410572 0.83 LMNA (0.46) NPC1RAB9AMAPTLMNA
SCHEMBL323498 0.82 MMP13 (0.43) ALDH1A1CYP2D6KMT2ASTAT3
SCHEMBL18410574 0.77 LMNA (0.49) P2RX4NPC1RAB9AMAPTLMNA
SCHEMBL18396809 0.77 STAT3 (0.45) ALDH1A1CYP2D6KMT2ASTAT3KDM4E
SCHEMBL30586531 0.76 MMP13 (0.46) ALDH1A1CYP2D6KMT2ASTAT3
SCHEMBL5968033 0.75 ALDH1A1 (0.41) ALDH1A1CYP2D6KMT2ANPC1RAB9A
SCHEMBL20328797 0.74 LMNA (0.46) NPC1RAB9AMAPTGAALMNA
SCHEMBL5968035 0.73 CHRM2 (0.41) ALDH1A1CYP2D6KMT2ANPC1RAB9A
SCHEMBL3951270 0.73 CYP2D6 (0.56) ALDH1A1CYP2D6KMT2ANPC1RAB9A
SCHEMBL26361860 0.73 MMP13 (0.45) ALDH1A1CYP2D6KMT2ARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2590953-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2013-05-15 EP disclosed
WO-2012004604-A1 TETRAZOLE COMPOUNDS AS CALCIUM CHANNEL BLOCKERS Convergence Pharmaceuticals Limited (GB) 2012-01-12 WO disclosed